AD	Adipose tissue
ACR	American college of rheumatology improvement criteria
APRIL	A proliferation-inducing ligand
BAFF	B-cell activating factor
BCMA	B-cell maturation antigen
BM	Bone marrow
BR3	B cell activation factor receptor 3
CAT	Computer-adaptive testing
anti-CCP	antibodies against cyclic citrullinated peptide
CDAI	Clinical disease activity index
CIA	Collagen-induced arthritis
CRP	C reactive protein
CXCR3	Chemokine receptor 3-alternative
DAS	Disease activity score
DMARDs	Disease-modifying antirheumatic drugs
ESR	Erythrocyte sedimentation rate
EULAR	European league against rheumatism
eASCs	expanded adipose-derived stem cells
HAQ	Health assessment questionnaire
HLA	Human leukocyte antigen
IA	Intra-articular
IL	Interleukin
IP	Intraperitoneal
IP10	IFN-γ-induced protein 10
IV	Intravenous
KHAQ	Korean health assessment questionnaire
MCP-1	Monocyte chemoattractant protein 1
MIP	Macrophage inflammatory protein 1
MHC	Major histocompatibility complex
MPCs	Multipotent progenitor cells
MSCs	Mesenchymal stromal/stem cells
NSAIDs	Non-steroidal anti-inflammatory drugs
PGA	Patient global assessment
RA	Rheumatoid arthritis
RANKL	Receptor activator of nuclear factor kappa-Β ligand
RAPID3	Routine assessment of patient index data 3
RANTES	Regulated on activation, normal T cell expressed and secreted
RF	Rheumatoid factor
SDAI	Simplex disease activity index
TACI	Transmembrane activator and CAML interactor
TGF-β 1	Transforming growth factor β 1
Tregs	Regulatory T cells
UC-MSCs	MSCs from umbilical cord
VAS	Visual analogue scale
WOMAC	Western Ontario and McMaster universities osteoarthritis index